FR2208659B1 - - Google Patents

Info

Publication number
FR2208659B1
FR2208659B1 FR7335619A FR7335619A FR2208659B1 FR 2208659 B1 FR2208659 B1 FR 2208659B1 FR 7335619 A FR7335619 A FR 7335619A FR 7335619 A FR7335619 A FR 7335619A FR 2208659 B1 FR2208659 B1 FR 2208659B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7335619A
Other languages
French (fr)
Other versions
FR2208659A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10464572A external-priority patent/JPS5110240B2/ja
Priority claimed from JP7146873A external-priority patent/JPS5019785A/ja
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of FR2208659A1 publication Critical patent/FR2208659A1/en
Application granted granted Critical
Publication of FR2208659B1 publication Critical patent/FR2208659B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7335619A 1972-10-19 1973-10-05 13-Alkyl, alkoxy or allyl berberrubin derivatives - anticancer agents, prepd by demethylation of a 13-subst berberine salt Granted FR2208659A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10464572A JPS5110240B2 (en) 1972-10-19 1972-10-19
JP7146873A JPS5019785A (en) 1973-06-25 1973-06-25

Publications (2)

Publication Number Publication Date
FR2208659A1 FR2208659A1 (en) 1974-06-28
FR2208659B1 true FR2208659B1 (en) 1977-09-09

Family

ID=26412563

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7335619A Granted FR2208659A1 (en) 1972-10-19 1973-10-05 13-Alkyl, alkoxy or allyl berberrubin derivatives - anticancer agents, prepd by demethylation of a 13-subst berberine salt

Country Status (1)

Country Link
FR (1) FR2208659A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130289A (en) * 1984-11-29 1986-06-18 Ss Pharmaceut Co Ltd Salt of 13-propylberberine

Also Published As

Publication number Publication date
FR2208659A1 (en) 1974-06-28

Similar Documents

Publication Publication Date Title
FR2208659B1 (en)
JPS546707B2 (en)
CS162148B1 (en)
CH578749A5 (en)
BG20556A3 (en)
BG21010A3 (en)
BG21231A3 (en)
CH4872A4 (en)
CH494772A4 (en)
CH545575A (en)
CH545622A (en)
CH545877A (en)
CH560132A5 (en)
CH560280A (en)
CH560979A5 (en)
CH561499A5 (en)
CH562125A5 (en)
CH563133A5 (en)
CH564358A5 (en)
CH564535A5 (en)
CH579151A5 (en)
CH565286A5 (en)
CH565416A5 (en)
CH567947A5 (en)
CH568006A5 (en)

Legal Events

Date Code Title Description
ST Notification of lapse